Sep 26, 2022 | Featured, Pharmacy Benefit Managers
Pharmacy Benefit Managers (PBMs) have become embedded in the ecosystem of drug pricing– but these middlemen are one of the reasons patients see high prices at the pharmacy counter. This episode is a crash course in everything drug pricing with a focus on PBMs, from...
Sep 21, 2022 | Letters Supported
Patients Rising Now and 12 other organizations sent a letter to the House of Representatives and Senate leadership encouraging support for the Preserving Access to Home Health Act of 2022 (H.R. 8581/S. 4605). There is currently a Centers for Medicare and Medicaid...
Sep 21, 2022 | Access, Featured
By Surabhi Dangi-Garimella, Ph.D. Pharmaceutical research, manufacturing, and marketing are long, nuanced, and expensive processes. While innovation in this space has a direct impact on both disease, prevention and disease outcomes, patients may often feel distant...
Sep 16, 2022 | Featured, Letters Supported
Patients Rising Now signed onto a letter to CMS Administrator Chiquita Brooks-LaSure calling for CMS to improve access to Chronic Kidney Disease (CKD) Treatment for Medicare beneficiaries. CKD and other kidney-related disorders are very common in both Americans aged...
Sep 14, 2022 | Featured, Statements
WASHINGTON — Patients Rising Now Co-Founder Terry Wilcox today released the following statement in response to the U.S. House passage of Improving Seniors’ Timely Access to Care Act (H.R.3173): “The prior authorization process has become incredibly burdensome to...
Sep 12, 2022 | Featured, Letters Supported
Patients Rising Now signed onto a letter urging Governor Newsom of California to sign SB 912 into law as soon as possible. SB 912 would require private and public health plans to recognize and cover biomarker tests. The practice of biomarker testing is where a...
Sep 12, 2022 | Advocacy, Featured
At Patients Rising, we are focused on the need to develop an all-inclusive, transparent healthcare system that provides patients access to affordable care. This is possible only when all stakeholders are at the table and have the ability to participate in the...
Sep 2, 2022 | Drug Costs, Featured
By Surabhi Dangi-Garimella, Ph.D. March-in rights have been invoked again, this time with the support of Senators Elizabeth Warren (D-Mass.) and Angus King (I-Maine), and Congressman Lloyd Doggett (D-Texas). March-in rights, a provision of the Bayh-Dole regulations,...
Aug 22, 2022 | Featured, Letters Submitted
Patients Rising Now sent a letter to the New York State Department of Financial Services about Pharmacy Benefit Managers. PBMs possess a considerable amount of leverage in the health space and use that leverage to steer patients to in-house or otherwise...
Aug 5, 2022 | Featured, Health Policy
WASHINGTON — Patients Rising NOW today released “What You Don’t Know About the Reconciliation Bill,” the organization’s fact-check of the drug pricing provisions within the Senate’s reconciliation bill, or the 725-page Inflation Reduction Act of 2022. The list...
